tyramine has been researched along with fluvoxamine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Koning, H; Korf, J; Venema, K; Wolf, H | 1 |
| Buitenhuis, C; Rutgers, M; Smets, LA; Tytgat, GA; Verwijs-Janssen, M; Voûte, PA | 1 |
| Barbosa-Filho, JM; de França Fonteles, MM; de Sousa, FC; Gaspar, DM; Gutierrez, SJ; Oliveira, IC; Rodrigues, GC; Vasconcelos, AS; Vasconcelos, SM; Vidal, LT | 1 |
| Matsumoto, M; Niwa, T; Shizuku, M; Yanai, M | 1 |
| Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Carvalho, AMR; de Sousa, FCF; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Mallmann, ASV; Oliveira, ICM; Oliveira, NF; Valentim, JT; Vasconcelos, SMM | 1 |
1 review(s) available for tyramine and fluvoxamine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for tyramine and fluvoxamine
| Article | Year |
|---|---|
Automated precolumn derivatization of amino acids, small peptides, brain amines and drugs with primary amino groups for reversed-phase high-performance liquid chromatography using naphthalenedialdehyde as the fluorogenic label.
Topics: Aldehydes; Amines; Amino Acids; Amphetamine; Animals; Antidepressive Agents; Baclofen; Brain Chemistry; Chromatography, High Pressure Liquid; Fluorescence; Fluvoxamine; Naphthalenes; Oximes; Peptides; Rats; Spermidine; Spermine; Tyramine | 1990 |
Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
Topics: 3-Iodobenzylguanidine; Animals; Biological Transport; Blood Platelets; Fluvoxamine; Humans; In Vitro Techniques; Iodobenzenes; Neuroblastoma; PC12 Cells; Rats; Serotonin; Sympatholytics; Tumor Cells, Cultured; Tyramine | 1993 |
Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus.
Topics: Anhedonia; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Female; Fluvoxamine; Hindlimb Suspension; Hippocampus; Interpersonal Relations; Mice; Motor Activity; Swimming; Tyramine | 2015 |
Effect of Cytochrome P450 (CYP) 2D6 Genetic Polymorphism on the Inhibitory Action of Antidepressants on CYP2D6-Mediated Dopamine Formation from p-Tyramine.
Topics: Antidepressive Agents; Brain; Cytochrome P-450 CYP2D6; Desipramine; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Humans; Imipramine; Polymorphism, Genetic; Structure-Activity Relationship; Tyramine | 2018 |
Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice.
Topics: Amides; Anhedonia; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Benzamides; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Disease Models, Animal; Ethylamines; Female; Fluvoxamine; Food Preferences; Hindlimb Suspension; Hippocampus; Mice; Sucrose; Tyramine | 2019 |